The clinical benefit of pegylated liposomal doxorubicin in patients with metastatic breast cancer previously treated with conventional anthracyclines: a multicentre phase II trial

Phase Ii ◽

Clinical Benefit ◽

Liposomal Doxorubicin ◽

Phase Ii Trial ◽

Metastatic Breast ◽

Multicentre Phase ◽

The Clinical Benefit of Pegylated Liposomal Doxorubicin in Patients With Metastatic Breast Cancer Previously Treated With Conventional Anthracyclines: A Multicentre Phase II Trial

Breast Diseases A Year Book Quarterly ◽

10.1016/s1043-321x(07)80277-3 ◽

2007 ◽

Vol 18 (2) ◽

pp. 205

Author(s):

A.C. Wolff

Keyword(s):

Breast Cancer ◽

Phase Ii ◽

Clinical Benefit ◽

Liposomal Doxorubicin ◽

Phase Ii Trial ◽

Metastatic Breast ◽

Multicentre Phase ◽

Reduced Incidence of Severe Palmar-Plantar Erythrodysesthesia and Mucositis in a Prospective Multicenter Phase II Trial with Pegylated Liposomal Doxorubicin at 40 mg/m2 Every 4 Weeks in Previously Treated Patients with Metastatic Breast Cancer

Oncology ◽

10.1159/000093005 ◽

2006 ◽

Vol 70 (2) ◽

pp. 141-146 ◽

Cited By ~ 37

Author(s):

Salah-Eddin Al-Batran ◽

Hans-Gerd Meerpohl ◽

Gunter von Minckwitz ◽

Akin Atmaca ◽

Ulrich Kleeberg ◽

...

Keyword(s):

Breast Cancer ◽

Phase Ii ◽

Liposomal Doxorubicin ◽

Phase Ii Trial ◽

Metastatic Breast ◽

Multicenter Phase ◽

Previously Treated Patients ◽

Pegylated liposomal doxorubicin and trastuzumab as 1st and 2nd line therapy in her2/neu positive metastatic breast cancer: a multicenter phase II trial

Breast Cancer Research and Treatment ◽

10.1007/s10549-008-0306-9 ◽

2009 ◽

Vol 117 (3) ◽

pp. 591-598 ◽

Cited By ~ 23

Author(s):

Elmar Stickeler ◽

Maximilian Klar ◽

Dirk Watermann ◽

Annette Geibel ◽

Martha Földi ◽

...

Keyword(s):

Breast Cancer ◽

Phase Ii ◽

Liposomal Doxorubicin ◽

Phase Ii Trial ◽

Metastatic Breast ◽

Multicenter Phase ◽

Line Therapy

A multi-centre phase II trial of pegylated liposomal doxorubicin and trastuzumab in HER-2 over-expressing metastatic breast cancer (MBC)

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.14_suppl.630 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 630-630 ◽

Cited By ~ 4

Author(s):

S. K. Chia ◽

M. Clemons ◽

L. A. Martin ◽

A. Rodgers ◽

K. Gelmon ◽

...

Keyword(s):

Breast Cancer ◽

Phase Ii ◽

Liposomal Doxorubicin ◽

Phase Ii Trial ◽

Metastatic Breast ◽

Her 2

A multi-centre phase II trial of pegylated liposomal doxorubicin and trastuzumab in HER-2 over-expressing metastatic breast cancer (MBC)

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.90140.630 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 630-630 ◽

Cited By ~ 2

Author(s):

S. K. Chia ◽

M. Clemons ◽

L. A. Martin ◽

A. Rodgers ◽

K. Gelmon ◽

...

Keyword(s):

Breast Cancer ◽

Phase Ii ◽

Liposomal Doxorubicin ◽

Phase Ii Trial ◽

Metastatic Breast ◽

Her 2

Myotax: A phase II trial of docetaxel plus non-pegylated liposomal doxorubicin as first-line therapy of metastatic breast cancer previously treated with adjuvant anthracyclines

European Journal of Cancer ◽

10.1016/j.ejca.2011.08.004 ◽

2011 ◽

Vol 47 (16) ◽

pp. 2396-2402 ◽

Cited By ~ 8

Author(s):

E. Curtit ◽

P. Nouyrigat ◽

N. Dohollou ◽

E. Levy ◽

A. Lortholary ◽

...

Keyword(s):

Breast Cancer ◽

Liposomal Doxorubicin ◽

Phase Ii Trial ◽

Metastatic Breast ◽

First Line ◽

First Line Therapy ◽

Line Therapy ◽

Phase II Trial of Pegylated Liposomal Doxorubicin in Combination With Gemcitabine in Metastatic Breast Cancer Patients

American Journal of Clinical Oncology ◽

10.1097/coc.0b013e3182005783 ◽

2012 ◽

Vol 35 (1) ◽

pp. 18-21 ◽

Cited By ~ 11

Author(s):

Jean-Philippe Jacquin ◽

Cyrus Chargari ◽

Julie Thorin ◽

Dominique Mille ◽

Adrien Mélis ◽

...

Keyword(s):

Breast Cancer ◽

Cancer Patients ◽

Phase Ii ◽

Liposomal Doxorubicin ◽

Phase Ii Trial ◽

Metastatic Breast ◽

Breast Cancer Patients

Non-pegylated liposomal doxorubicin and docetaxel in metastatic breast cancer: final results of a phase II trial

Cancer Chemotherapy and Pharmacology ◽

10.1007/s00280-008-0887-3 ◽

2008 ◽

Vol 64 (2) ◽

pp. 401-406 ◽

Cited By ~ 8

Author(s):

Peter Schmid ◽

J. Krocker ◽

R. Kreienberg ◽

P. Klare ◽

K. Kittel ◽

...

Keyword(s):

Breast Cancer ◽

Phase Ii ◽

Liposomal Doxorubicin ◽

Phase Ii Trial ◽

Metastatic Breast ◽

Pegylated Liposomal Doxorubicin

Pegylated liposomal doxorubicin and gemcitabine in the front-line treatment of recurrent/metastatic breast cancer: a multicentre phase II study

British Journal of Cancer ◽

10.1038/sj.bjc.6604409 ◽

2008 ◽

Vol 98 (12) ◽

pp. 1916-1921 ◽

Cited By ~ 17

Author(s):

V Adamo ◽

V Lorusso ◽

R Rossello ◽

B Adamo ◽

G Ferraro ◽

...

Keyword(s):

Breast Cancer ◽

Phase Ii ◽

Liposomal Doxorubicin ◽

Phase Ii Study ◽

Metastatic Breast ◽

Line Treatment ◽

Front Line ◽

Multicentre Phase

A Phase II Trial of Vinorelbine and Pegylated Liposomal Doxorubicin in Patients With Pretreated Metastatic Breast Cancer

American Journal of Clinical Oncology ◽

10.1097/01.coc.0000251400.47711.fe ◽

2007 ◽

Vol 30 (2) ◽

pp. 133-138 ◽

Cited By ~ 10

Author(s):

Louis Wing-Cheong Chow ◽

Adrian Yun-San Yip ◽

Brian Hung-Hin Lang

Keyword(s):

Breast Cancer ◽

Phase Ii ◽

Liposomal Doxorubicin ◽

Phase Ii Trial ◽

Metastatic Breast ◽

Pegylated Liposomal Doxorubicin